OTC · Drug Manufacturers - Specialty & Generic

Fifty 1 Labs, Inc. (FITY) Stock

$0.00 OTC: FITY Healthcare

Fifty 1 Labs, Inc. is a Nevada-based holding company that has shifted its focus to biotechnology and telehealth, centering on peptide science for musculoskeletal health, recovery, and performance.

Valuation

MetricValue
Price$0.00
Market Cap$228751
P/E Ratio6.00
P/B Ratio-2.46
P/S Ratio0.12
EPS (TTM)$0.00
52-Week High$0.00
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE28.76%
ROA-12.04%
ROCE29.03%
Gross Margin63.37%
Operating Margin-12.81%
Net Margin-51.56%
Debt/Equity-0.88
Current Ratio0.33

Annual Financials (USD)

Metric20202021202220232024
Revenue$0$0$0$0$0
Operating Profit$0$0$-1.0M$0$0
Net Profit$0$0$-1.0M$0$0
EPS$0.00$0.00$0.00$0.00$0.00
Op Margin-85.4%-362.7%-572.1%-1733.3%—

Balance Sheet (USD)

Metric20202021202220232024
Total Assets$0$0$0$0$0
Total Liabilities$0$0$0$0$0
Cash$0$0$0$0$0
Borrowings$0$0$0$0$0

Cash Flow (USD)

Metric20202021202220232024
Operating Cash Flow$0$0$0$0—
Investing Cash Flow$0$0$0$0—
Financing Cash Flow$0$0$0$0—
Net Cash Flow$0$0$0$0—
Free Cash Flow$0$0$0$0$0

Valuation & Return Ratios

MetricValue
PEG Ratio0.04
EV / EBITDA-7.19
FCF Yield-6.12%
Quick Ratio0.00
Interest Coverage0.00
Return 1Y-84.85%
Return 3Y-97.56%
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AIJTYJianpu Technology Inc. $0.85 +0.00% 0.18 $852114 2.31%
ATNPQAtlantis Technology Group $0.00 — -0.10 $925827 0.00%
CNERBioEnergy Development Inc. $0.01 +0.00% 14.00 $717524 0.00%
CSOLChina Solar & Clean Energy Solutions, Inc. $0.01 +0.00% -36.00 $406973 0.00%
FNNZFFinCanna Capital Corp. $0.00 — 0.14 $2.89M 0.00%

About Fifty 1 Labs, Inc.

Fifty 1 Labs, Inc. is a Nevada-based holding company that has shifted its focus to biotechnology and telehealth, centering on peptide science for musculoskeletal health, recovery, and performance. The company utilizes AI-driven research and aims to develop a telehealth platform for personalized peptide therapies. Formerly involved in automotive finance, the company is now pursuing growth in the functional medicine and life sciences sectors.

Fifty 1 Labs, Inc. (FITY) stock trades at $0.00 with a market capitalization of $228751. The stock is valued at a price-to-earnings (P/E) ratio of 6.00, price-to-book of -2.46, price-to-sales of 0.12. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, Fifty 1 Labs, Inc. generates a return on equity (ROE) of 28.76% — well above the market average, a sign of a high-quality business, return on capital employed of 29.03%, an operating margin of -12.81%, a net profit margin of -51.56%.

Official website: fifty1labs.com

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides